Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Breast Cancer Res Treat. 2017 Feb 21;163(1):167–176. doi: 10.1007/s10549-017-4158-z

Figure 2b.

Figure 2b

Predicted testing rates adjusted for case-mix, by practice group, Kaiser Permanente Northern California, 2013–15. The adjusted rate represents the percent of eligible patients predicted to have the multigene test, if all eligible patients from practice group A were seen at the practice group indicated.